TAYLOR MORRISON HOME CORP (TMHC) Fundamental Analysis & Valuation

NYSE:TMHC • US87724P1066

Current stock price

57.33 USD
-1.56 (-2.65%)
At close:
57.33 USD
0 (0%)
After Hours:

This TMHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. TMHC Profitability Analysis

1.1 Basic Checks

  • In the past year TMHC was profitable.
  • TMHC had a positive operating cash flow in the past year.
  • TMHC had positive earnings in each of the past 5 years.
  • In the past 5 years TMHC always reported a positive cash flow from operatings.
TMHC Yearly Net Income VS EBIT VS OCF VS FCFTMHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

1.2 Ratios

  • TMHC has a Return On Assets of 7.95%. This is in the better half of the industry: TMHC outperforms 80.00% of its industry peers.
  • Looking at the Return On Equity, with a value of 12.43%, TMHC is in the better half of the industry, outperforming 68.33% of the companies in the same industry.
  • TMHC has a Return On Invested Capital of 9.79%. This is in the better half of the industry: TMHC outperforms 71.67% of its industry peers.
  • TMHC had an Average Return On Invested Capital over the past 3 years of 10.70%. This is in line with the industry average of 9.21%.
Industry RankSector Rank
ROA 7.95%
ROE 12.43%
ROIC 9.79%
ROA(3y)8.77%
ROA(5y)9.27%
ROE(3y)13.99%
ROE(5y)16.32%
ROIC(3y)10.7%
ROIC(5y)11.15%
TMHC Yearly ROA, ROE, ROICTMHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 9.63%, TMHC belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
  • TMHC's Profit Margin has improved in the last couple of years.
  • TMHC has a better Operating Margin (13.87%) than 85.00% of its industry peers.
  • TMHC's Operating Margin has improved in the last couple of years.
  • TMHC has a Gross Margin of 23.38%. This is in the lower half of the industry: TMHC underperforms 61.67% of its industry peers.
  • TMHC's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.87%
PM (TTM) 9.63%
GM 23.38%
OM growth 3Y-6.43%
OM growth 5Y13.93%
PM growth 3Y-9.03%
PM growth 5Y19.4%
GM growth 3Y-2.77%
GM growth 5Y6.54%
TMHC Yearly Profit, Operating, Gross MarginsTMHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. TMHC Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so TMHC is still creating some value.
  • The number of shares outstanding for TMHC has been reduced compared to 1 year ago.
  • The number of shares outstanding for TMHC has been reduced compared to 5 years ago.
  • Compared to 1 year ago, TMHC has a worse debt to assets ratio.
TMHC Yearly Shares OutstandingTMHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
TMHC Yearly Total Debt VS Total AssetsTMHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • TMHC has an Altman-Z score of 3.65. This indicates that TMHC is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.65, TMHC is doing good in the industry, outperforming 61.67% of the companies in the same industry.
  • The Debt to FCF ratio of TMHC is 2.95, which is a good value as it means it would take TMHC, 2.95 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of TMHC (2.95) is better than 65.00% of its industry peers.
  • TMHC has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
  • TMHC has a Debt to Equity ratio (0.36) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 2.95
Altman-Z 3.65
ROIC/WACC1.05
WACC9.33%
TMHC Yearly LT Debt VS Equity VS FCFTMHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 6.81 indicates that TMHC has no problem at all paying its short term obligations.
  • TMHC's Current ratio of 6.81 is fine compared to the rest of the industry. TMHC outperforms 78.33% of its industry peers.
  • A Quick Ratio of 1.03 indicates that TMHC should not have too much problems paying its short term obligations.
  • TMHC has a Quick ratio (1.03) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 6.81
Quick Ratio 1.03
TMHC Yearly Current Assets VS Current LiabilitesTMHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. TMHC Growth Analysis

3.1 Past

  • TMHC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.51%.
  • Measured over the past years, TMHC shows a very strong growth in Earnings Per Share. The EPS has been growing by 23.33% on average per year.
  • The Revenue has decreased by -0.57% in the past year.
  • TMHC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.79% yearly.
EPS 1Y (TTM)-7.51%
EPS 3Y-5.31%
EPS 5Y23.33%
EPS Q2Q%-23.48%
Revenue 1Y (TTM)-0.57%
Revenue growth 3Y-0.42%
Revenue growth 5Y5.79%
Sales Q2Q%-9.74%

3.2 Future

  • The Earnings Per Share is expected to decrease by -7.89% on average over the next years.
  • Based on estimates for the next years, TMHC will show a decrease in Revenue. The Revenue will decrease by -4.12% on average per year.
EPS Next Y-31.91%
EPS Next 2Y-7.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-15.55%
Revenue Next 2Y-4.12%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TMHC Yearly Revenue VS EstimatesTMHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
TMHC Yearly EPS VS EstimatesTMHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

7

4. TMHC Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 7.39, the valuation of TMHC can be described as very cheap.
  • Compared to the rest of the industry, the Price/Earnings ratio of TMHC indicates a rather cheap valuation: TMHC is cheaper than 88.33% of the companies listed in the same industry.
  • TMHC is valuated cheaply when we compare the Price/Earnings ratio to 24.88, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 10.85 indicates a reasonable valuation of TMHC.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of TMHC indicates a somewhat cheap valuation: TMHC is cheaper than 63.33% of the companies listed in the same industry.
  • TMHC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.19.
Industry RankSector Rank
PE 7.39
Fwd PE 10.85
TMHC Price Earnings VS Forward Price EarningsTMHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, TMHC is valued a bit cheaper than the industry average as 71.67% of the companies are valued more expensively.
  • Based on the Price/Free Cash Flow ratio, TMHC is valued cheaply inside the industry as 88.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 7.11
EV/EBITDA 6.1
TMHC Per share dataTMHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

  • The decent profitability rating of TMHC may justify a higher PE ratio.
  • TMHC's earnings are expected to decrease with -7.89% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.32
EPS Next 2Y-7.89%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. TMHC Dividend Analysis

5.1 Amount

  • No dividends for TMHC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

TMHC Fundamentals: All Metrics, Ratios and Statistics

TAYLOR MORRISON HOME CORP

NYSE:TMHC (3/27/2026, 8:04:00 PM)

After market: 57.33 0 (0%)

57.33

-1.56 (-2.65%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)02-11
Earnings (Next)04-21
Inst Owners101.52%
Inst Owner Change1.1%
Ins Owners0.59%
Ins Owner Change13.67%
Market Cap5.52B
Revenue(TTM)8.12B
Net Income(TTM)782.50M
Analysts78.75
Price Target77.32 (34.87%)
Short Float %5.6%
Short Ratio5.05
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.42%
Min EPS beat(2)-1.84%
Max EPS beat(2)1.01%
EPS beat(4)2
Avg EPS beat(4)1.13%
Min EPS beat(4)-2.85%
Max EPS beat(4)8.2%
EPS beat(8)5
Avg EPS beat(8)2.57%
EPS beat(12)7
Avg EPS beat(12)4.91%
EPS beat(16)10
Avg EPS beat(16)6.03%
Revenue beat(2)0
Avg Revenue beat(2)-1.29%
Min Revenue beat(2)-2.35%
Max Revenue beat(2)-0.24%
Revenue beat(4)2
Avg Revenue beat(4)1.08%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)4.54%
Revenue beat(8)5
Avg Revenue beat(8)0.84%
Revenue beat(12)9
Avg Revenue beat(12)3%
Revenue beat(16)12
Avg Revenue beat(16)2.4%
PT rev (1m)0.12%
PT rev (3m)3.2%
EPS NQ rev (1m)-24.38%
EPS NQ rev (3m)-29.02%
EPS NY rev (1m)-19.78%
EPS NY rev (3m)-23.44%
Revenue NQ rev (1m)-14.33%
Revenue NQ rev (3m)-13.79%
Revenue NY rev (1m)-5.47%
Revenue NY rev (3m)-6.68%
Valuation
Industry RankSector Rank
PE 7.39
Fwd PE 10.85
P/S 0.68
P/FCF 7.11
P/OCF 6.76
P/B 0.88
P/tB 0.98
EV/EBITDA 6.1
EPS(TTM)7.76
EY13.54%
EPS(NY)5.28
Fwd EY9.22%
FCF(TTM)8.07
FCFY14.07%
OCF(TTM)8.48
OCFY14.8%
SpS84.31
BVpS65.33
TBVpS58.45
PEG (NY)N/A
PEG (5Y)0.32
Graham Number106.8
Profitability
Industry RankSector Rank
ROA 7.95%
ROE 12.43%
ROCE 12.83%
ROIC 9.79%
ROICexc 10.84%
ROICexgc 11.83%
OM 13.87%
PM (TTM) 9.63%
GM 23.38%
FCFM 9.57%
ROA(3y)8.77%
ROA(5y)9.27%
ROE(3y)13.99%
ROE(5y)16.32%
ROIC(3y)10.7%
ROIC(5y)11.15%
ROICexc(3y)11.72%
ROICexc(5y)12.31%
ROICexgc(3y)13.58%
ROICexgc(5y)14.24%
ROCE(3y)14.02%
ROCE(5y)14.61%
ROICexgc growth 3Y-12.31%
ROICexgc growth 5Y15.36%
ROICexc growth 3Y-12.76%
ROICexc growth 5Y14.64%
OM growth 3Y-6.43%
OM growth 5Y13.93%
PM growth 3Y-9.03%
PM growth 5Y19.4%
GM growth 3Y-2.77%
GM growth 5Y6.54%
F-Score5
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 2.95
Debt/EBITDA 1.96
Cap/Depr 100.47%
Cap/Sales 0.5%
Interest Coverage 250
Cash Conversion 70.07%
Profit Quality 99.29%
Current Ratio 6.81
Quick Ratio 1.03
Altman-Z 3.65
F-Score5
WACC9.33%
ROIC/WACC1.05
Cap/Depr(3y)96.24%
Cap/Depr(5y)86.45%
Cap/Sales(3y)0.46%
Cap/Sales(5y)0.41%
Profit Quality(3y)73.15%
Profit Quality(5y)75.08%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.51%
EPS 3Y-5.31%
EPS 5Y23.33%
EPS Q2Q%-23.48%
EPS Next Y-31.91%
EPS Next 2Y-7.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.57%
Revenue growth 3Y-0.42%
Revenue growth 5Y5.79%
Sales Q2Q%-9.74%
Revenue Next Year-15.55%
Revenue Next 2Y-4.12%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-6.24%
EBIT growth 3Y-6.83%
EBIT growth 5Y20.52%
EBIT Next Year-28.08%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y347.18%
FCF growth 3Y-10.32%
FCF growth 5Y-6.47%
OCF growth 1Y289.07%
OCF growth 3Y-9.64%
OCF growth 5Y-6.16%

TAYLOR MORRISON HOME CORP / TMHC Fundamental Analysis FAQ

What is the ChartMill fundamental rating of TAYLOR MORRISON HOME CORP (TMHC) stock?

ChartMill assigns a fundamental rating of 5 / 10 to TMHC.


What is the valuation status for TMHC stock?

ChartMill assigns a valuation rating of 7 / 10 to TAYLOR MORRISON HOME CORP (TMHC). This can be considered as Undervalued.


How profitable is TAYLOR MORRISON HOME CORP (TMHC) stock?

TAYLOR MORRISON HOME CORP (TMHC) has a profitability rating of 7 / 10.


What is the earnings growth outlook for TAYLOR MORRISON HOME CORP?

The Earnings per Share (EPS) of TAYLOR MORRISON HOME CORP (TMHC) is expected to decline by -31.91% in the next year.